Therefore, we concluded that downregulation of SGOL2 expression inhibited the expression of MAD2, thereby reducing the levels of cyclin D1 and cyclin E1, inducing cell cycle arrest in the G1/S phase, and inhibiting the proliferation of HCC cells. This evidence concerns the gene SGO2 and hepatocellular carcinoma.